Summit: Participant Recruitment and Retention

Practical methods for recruiting and retaining research participants.


About these Courses

Recruiting and retaining participants comprise core components of clinical trials. The series describes methods for building trust with participants who are a “good fit” for the clinical trial. It explains the importance of IRB-approved recruiting scripts, advertising, and pre-screening activities highlights the advantages of physician-to-physician networks and referrals. The series also details methods for managing participant involvement in clinical trials. It provides insights into how keep study participants engaged and compliant and how to lessen participant attrition.

Note: Summit: Participant Recruitment is available now. Summit: Participant Retention will be released soon.

View Preview:

Language Availability: English

Suggested Audiences: Clinical Research Coordinators (CRCs), Contract Research Organizations (CROs), Faculty, Investigators, Research Administrators, Study Sites


Basic Courses

Summit: Participant Recruitment
New

Provides practical methods for recruiting participants for clinical trials.

female doctor consulting overweight patient


FAQs

What courses are included in the Summit: Participant Recruitment and Retention series?

Summit: Participant Recruitment and Summit: Participant Retention (coming soon) courses comprise the series.

Who should take the Summit: Participant Recruitment and Retention courses?

The course is specifically intended for those who are responsible for recruiting and managing clinical trial participants. Intended audiences include Clinical Research Coordinators (CRCs), Contract Research Organizations (CROs), faculty, investigators, research administrators, students, and study sites.

How long will these courses take a learner to complete?

These one module courses can be completed in 30-40 minutes.

Are these courses eligible for continuing medical education credits?

This course does not currently have CE/CME credits available.